Ken Griffin Dare Bioscience, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Shares
15 transactions
Others Institutions Holding DARE
# of Institutions
3Shares Held
267KCall Options Held
0Put Options Held
0About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $270M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...